[go: up one dir, main page]

IL28401A - Arylsulfonyl ureas,their manufacture and pharmaceutical compositions containing them - Google Patents

Arylsulfonyl ureas,their manufacture and pharmaceutical compositions containing them

Info

Publication number
IL28401A
IL28401A IL28401A IL2840167A IL28401A IL 28401 A IL28401 A IL 28401A IL 28401 A IL28401 A IL 28401A IL 2840167 A IL2840167 A IL 2840167A IL 28401 A IL28401 A IL 28401A
Authority
IL
Israel
Prior art keywords
general formula
manufacture
same meaning
process according
acid
Prior art date
Application number
IL28401A
Original Assignee
Hoffmann La Roche
Sparamedica Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from CH1136566A external-priority patent/CH500176A/en
Application filed by Hoffmann La Roche, Sparamedica Ag filed Critical Hoffmann La Roche
Publication of IL28401A publication Critical patent/IL28401A/en

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D295/00Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms
    • C07D295/22Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with hetero atoms directly attached to ring nitrogen atoms
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/64Sulfonylureas, e.g. glibenclamide, tolbutamide, chlorpropamide
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C311/00Amides of sulfonic acids, i.e. compounds having singly-bound oxygen atoms of sulfo groups replaced by nitrogen atoms, not being part of nitro or nitroso groups
    • C07C311/50Compounds containing any of the groups, X being a hetero atom, Y being any atom
    • C07C311/52Y being a hetero atom
    • C07C311/54Y being a hetero atom either X or Y, but not both, being nitrogen atoms, e.g. N-sulfonylurea
    • C07C311/57Y being a hetero atom either X or Y, but not both, being nitrogen atoms, e.g. N-sulfonylurea having sulfur atoms of the sulfonylurea groups bound to carbon atoms of six-membered aromatic rings
    • C07C311/59Y being a hetero atom either X or Y, but not both, being nitrogen atoms, e.g. N-sulfonylurea having sulfur atoms of the sulfonylurea groups bound to carbon atoms of six-membered aromatic rings having nitrogen atoms of the sulfonylurea groups bound to carbon atoms of rings other than six-membered aromatic rings
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D263/00Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings
    • C07D263/02Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings not condensed with other rings
    • C07D263/08Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member
    • C07D263/16Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D263/28Nitrogen atoms not forming part of a nitro radical
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C2601/00Systems containing only non-condensed rings
    • C07C2601/06Systems containing only non-condensed rings with a five-membered ring
    • C07C2601/08Systems containing only non-condensed rings with a five-membered ring the ring being saturated
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C2601/00Systems containing only non-condensed rings
    • C07C2601/12Systems containing only non-condensed rings with a six-membered ring
    • C07C2601/14The ring being saturated

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Epidemiology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Nitrogen And Oxygen As The Only Ring Hetero Atoms (AREA)

Description

Arylsulfonyl their manufacture and pharmaceutical compositions containing them SPARAMEDICA This invention to novel sulfonamides and to a process for the manufactwe In one the novel sulfonamides of the invention are sul onylurea derivatives of the general formul 1 2 wherei represents hydroge R represents 1 or R and R taken together represent represents a phenyl radical bearing one or lower lower o lower ethyl or a or containing heterocyclic and n is 3 or The compounds of the invention may be manufactured by a process comprising reacting a reactive derivative of a sulfonylcarbamlc acid of the general ormula o a sulfonylisocyanate of the general formula solvents which do not contain hydroxy such as halogenated hydrocarbons such as or In a preferred embodiment of process variant there is used a compound of the general formula in which Z presents the a sulfonamide as an alkali is reacted with zole in a suitable anhydrous organic solvent of the kind tioned The acid imidazolide which is formed is allowed to react in situ with r or When a cyclic is the keto group in the reaction product obtained can be subsequently reduced to the hydroxyl This can be effected in a manner known per for by treatment with a complex metal hydride such as sodium isomers obtained in the reduction can if be separated according to methods known per se by crystallization by On the other a hydroxy group contained in the reaction product can be to the keto group in a manner known per se by means of chromic ί The starting compounds of the above formula IV can be by reaoting a sulfonylcarbamio acid derivative o a sulfonylisocyanate with a or 50 ml of treated at with g of The reaction mixture was at for a further 20 minutes then treated with g cls The reaction was allowed to warm up to room stirred for a further 2 hours and evaporated in The residue taken up in 60 ml of caustic soda and the solution was with The ethereal was extracted 40 ml of caustic soda and the combined aqueous j were made with hydrochloric The solution was extracted with acetic ester and working up of ester extract yielded melting point Example 2 Following a similar procedure to that described in Example 1 from acid zolide in situ from and there was tained melting point Example 3 Following a similar prooedure to that described in Example from and melting Exam le 4 A mixture of 7 8 g of acid ethyl g of and ml of absolute pyridine was heated at for hours in the absence of The oily reaction product was dissolved 100 ml of caustic soda and after extraction with aqueous phase was saturated with C02 and The i jfiltrate was acidified with acetic acid and the which separated out crystallized on standing and was recrystallized ester The product decomposed above ί Example 5 i j 8 g of oxazolidinone in 150 ml of caustic soda were heated to reflux for about After the reaction solution was acidified with hydrochloric The reaction which separated out as an oil crystallized on standing and i reprecipitated by dissolving in soda solution and ί fication of the solution with hydrochloric The 1 t melted at The starting material was manufactured as melting Example 10 A solution of g of in 400 ml of acetone was treated with an aqueous chromic acid solution g of per 100 up to the positive The mixture was then treated with about 500 ml of water in order to dissolve the chromium salt and acetone was evaporated in The aqueous residue was with and extract washed with salt dried and evaporated There was obtained oluenesulfonyl melting point Example 11 j To a solution of 5 75 S of trans 50 ml of absolute after the addition of ml of there were slowly with and 17 ml of standing for 2 days at room the solvent evaporated the residue dissolved in ml of On saturation of the solution with there was precipitated a brown resin from which the mother liquor was After extraction with the aqueous solution was insufficientOCRQuality

Claims (1)

1. A compound of the general formula 1 wherein R represents hydroge R represents o taken together represent R represents phenyl radical bearing one or more lowe alkylthio or lower ethyl or a or heterocyclic grou and n is 3 or urea 16 A process for the manufacture of hovel sulfonamides the general formula I in Claim wherein a reactive derivative sulfonylearbamic acid the general formula or a sulfonylisocyanate of the general formula in which formulae has the same meaning in Claim is acted with cyclohexanone or A process according to Claim wherein a pound of general formula wherein has the same meaning as in 1 and is lower lower or is used as a reactive earbamic acid A rocess accordin to Claim 1 or 1 where n 18 which formulae and n have the same meaning as in Claim is treated with an Process for the preparation of sulfonamides I in 1 as hereinbefore particularly especially with to the Process for the manufacture of preparations having sugar depressing characterized in that a amide of genera formula I is as active s with therapeuticall compatible olid or liquid used in blood sugar depressant containin a sulfonamide of the general formula I in Claim and a A compound of the general formula I in Claim 1 whenever prepared by a process according to any one of Claims 13 to 20 by an obvious ohemical equivalent whenever prepared by a process according to any one of Claims 13 to or by an obvious chemical equivalent insufficientOCRQuality
IL28401A 1966-08-08 1967-07-26 Arylsulfonyl ureas,their manufacture and pharmaceutical compositions containing them IL28401A (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
CH1136566A CH500176A (en) 1966-08-08 1966-08-08 Sulphonamides and process for the manufacture thereof
CH787469A CH509991A (en) 1966-08-08 1966-08-08 Sulphonamides and process for the manufacture thereof
CH787569A CH509992A (en) 1966-08-08 1966-08-08 Process for the preparation of sulfonamides

Publications (1)

Publication Number Publication Date
IL28401A true IL28401A (en) 1971-04-28

Family

ID=27175874

Family Applications (1)

Application Number Title Priority Date Filing Date
IL28401A IL28401A (en) 1966-08-08 1967-07-26 Arylsulfonyl ureas,their manufacture and pharmaceutical compositions containing them

Country Status (11)

Country Link
JP (1) JPS5516575B1 (en)
BE (1) BE702280A (en)
CH (2) CH509992A (en)
DE (1) DE1668199B2 (en)
DK (1) DK122761B (en)
ES (1) ES343910A1 (en)
FR (1) FR7148M (en)
GB (3) GB1147403A (en)
IL (1) IL28401A (en)
NL (1) NL6710676A (en)
SE (1) SE334354B (en)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
PE20221627A1 (en) 2015-02-16 2022-10-19 Univ Queensland SULFONYLUREAS AND RELATED COMPOUNDS AND USE OF THESE
BR112019024831A2 (en) 2017-05-24 2020-06-09 The University Of Queensland compound, salt, solvate or prodrug, pharmaceutical composition, method of treating or preventing a disease, method of inhibiting nlrp3
PT3661925T (en) 2017-07-07 2022-01-31 Inflazome Ltd Novel sulfonamide carboxamide compounds

Also Published As

Publication number Publication date
GB1147403A (en) 1969-04-02
CH509991A (en) 1971-07-15
CH509992A (en) 1971-07-15
SE334354B (en) 1971-04-26
FR7148M (en) 1969-08-04
GB1147405A (en) 1969-04-02
DE1668199A1 (en) 1971-09-02
JPS5516575B1 (en) 1980-05-02
ES343910A1 (en) 1968-10-01
BE702280A (en) 1968-02-05
NL6710676A (en) 1968-02-09
DK122761B (en) 1972-04-10
DE1668199B2 (en) 1976-06-24
GB1147404A (en) 1969-04-02

Similar Documents

Publication Publication Date Title
US2554816A (en) Heterocyclic sulfonamides and methods of preparation thereof
US2595334A (en) Benzothiazolesulfonamides and method of preparing the same
IL28401A (en) Arylsulfonyl ureas,their manufacture and pharmaceutical compositions containing them
US2455894A (en) Production of 1-mono-and 1, 2-disubstituted-3-cyanoguanidines
US2072348A (en) Chlorinated trialkyl amines and method of producing
DE949742C (en) Process for the preparation of N-allyl normorphine from normorphine and allyl halide
US3325515A (en) Coumarin derivatives and their preparation
US2603649A (en) Heterocyclic sulfonamides and method of preparing the same
US2740781A (en) 3, 26-dihydroxy-16, 22-imino-5-cholestenes, 3, 26-dihydroxy-16, 22-imino-5, 16, 20(22)-cholestatrienes and derivatives thereof
US2664428A (en) delta-17 alpha-hydroxy-3,20-diketo-pregnen-21-als
NO122920B (en)
US2863873A (en) Esters of nicotinic acid
US3350407A (en) Sulfur containing pyrazole derivatives
IL22148A (en) Benzenesulfonyl ureas
NO133892B (en)
US3234210A (en) New ureas and process for preparing same
US3444167A (en) Process for the production of thiamine derivatives
US3068238A (en) 3-cyano, 4-hydroxy-1, 2, 5-thiadiazole, derivatives and process
US3183232A (en) O, s-disubstituted thiol-type thiamines
US2673873A (en) Basic esters of 9, 10-dihalogenated 9, 10-dihydro-9, 10-ethanoanthracene-11-carboxylic acids and their derivatives
SU436492A3 (en) METHOD FOR OBTAINING DERIVATIVES OF PICOLINE WASTE ACIDS
US3152123A (en) Process for the preparation of benzo-
AT277277B (en) PROCESS FOR MANUFACTURING NEW SULFONYL URENE DERIVATIVES
US3322760A (en) 6-(substituted-amino)-1-tetralones
US3468889A (en) O-and/or s-nicotinoyl diacylthiamines and acylation process for preparing the same